Peter Altman - 02 Jul 2026 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Reporting relationship: President and CEO, Director
Issuer ticker: BCDA
Reported as of: 02 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 07 Jul 2026, 22:03:33 UTC
Prior SEC filing: 01 Jul 2026
Next SEC filing: 10 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ David McClung, by power of attorney

Key filing fact

Peter Altman filed Form 4 for BioCardia, Inc. (BCDA) on 07 Jul 2026.

Key facts

This page summarizes Peter Altman's Form 4 filing for BioCardia, Inc. (BCDA).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Jul 2026, 22:03.

Change

Previous filing in this sequence was filed on 01 Jul 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001647542 Primary reporting owner

Altman Peter

Relationship: President and CEO, Director
Address: C/O BIOCARDIA, INC., 320 SOQUEL WAY, SUNNYVALE
Signature: /s/ David McClung, by power of attorney
Signature date: 07 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BCDA transaction

Common Stock

Tax liability

Transaction value
Shares: -54,606
Change %: -13%
Price: $1.24^*
Shares after: 356,585
Date: 02 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BCDA transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +57,688
Change %: +64%
Price: $0.000000^*
Shares after: 147,903
Date: 06 Jul 2026
Ownership: Direct
Underlying class: Common stock
Underlying amount: 57,688
Exercise price: $1.20
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reported securities represent the shares that have been withheld by the Issuer to satisfy its income tax, withholding and remittance obligations in connection with the net settlement on July 2, 2026, of the RSUs vested on June 29, 2026 and does not represent a sale by the Reporting Person.

Footnote F2

The option vests and becomes exercisable as to 1/48th of the shares on August 6, 2026, and each month thereafter, subject to the Reporting Person continuing as a service provider through such date.